Bulk Quote Inquiry

COV-VM1SM-100μg / Inquiry

COV-VM1SM-500μg / Inquiry

COV-VM1SM-1mg / Inquiry

SARS-COV-2 Spike S1 (N501Y,K417N,E484K) Protein

Product Info
Source

Recombinant SARS-COV-2 Spike S1 (N501Y,K417N,E484K) Protein is expressed from Expi293 with His tag at the C-terminal. It contains Val16-Arg685(N501Y,K417N,E484K).[Accession | YP_009724390.1]

Molecular Weight

The protein has a predicted MW of 75.9 kDa. Due to glycosylation, the protein migrates to 90-130 kDa based on Tris-Bis PAGE result.

Endotoxin

Less than 1EU per μg by the LAL method.

Purity

> 95% as determined by Tris-Bis PAGE
> 95% as determined by HPLC

Formulation

Supplied as 0.22μm filtered solution in PBS (pH 7.4).

Storage

The product should be stored at -70℃. Please do not repeated freeze-thaw cycles.

Assay Data
Tris-Bis PAGE

SARS-COV-2 Spike S1 (N501Y,K417N,E484K) on Tris-Bis PAGE under reduced condition. The purity is greater than 95%.

SEC-HPLC

The purity of SARS-COV-2 Spike S1 (N501Y,K417N,E484K) is greater than 95% as determined by SEC-HPLC.

Background

The spike protein (S) of coronavirus (CoV) attaches the virus to its cellular receptor, angiotensin-converting enzyme 2 (ACE2). A defined receptor-binding domain (RBD) on S mediates this interaction.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity.

Synonyms

S1 protein; Spike protein S1; Spike,S1 protein; S glycoprotein Subunit1

References

(1)Belouzard S , Chu V C , Whittaker G R . Activation Of The Sars Coronavirus Spike Protein Via Sequential Proteolytic Cleavage At Two Distinct Sites[J]. Proceedings of the National Academy of Sciences of the United States of America, 2009, 106(14):5871-5876.

Kactus Biosystems Co.Ltd
Online Message